Department of Neurosurgery, Wenzhou People's Hospital, Wenzhou, Zhejiang Province, China 325000.
Department of Vascular & Interventional Radiology, Wenzhou People's Hospital, Wenzhou, Zhejiang Province, China 325000.
Dis Markers. 2022 Jul 15;2022:2231195. doi: 10.1155/2022/2231195. eCollection 2022.
Finding miR-339-5p inhibitory functions in glioma through PTP4A1/HMGB1 pathway.
From May 2020 to August 2021, 20 glioblastoma and para cancer tissues were chosen for qRT-PCR analysis. The miR-NC, miR-con, miR-339-5PMIMIC, and miR-con + groups were transfected into human glioma U251 cells. The capacity of cell vascular-like structure construction was found by simulating angiogenesis, and the ability of cell movement was examined by cell scratching. The twofold luciferase reporter gene method determined that miR-339-5p targets PTP4A1, and the protein expression levels of PTP4A1 and HMGB1 were examined using Western blot.
MiR-339-5P expression was substantially lower in cancer samples than noncancer samples ( < 0.05). PTP4A1 expression in cancer samples was higher than in healthy controls ( < 0.05). The miR-339-5p group produced significantly less vascular-like structures than the NC and miR-con groups ( < 0.05). The miR-339-5p group lowered the invasive index and migratory rate of U251 cells ( < 0.05). PTP4A1 inhibited the luciferase activity of the pTP4A1-WT reporter gene ( < 0.05) but not the PTP4A1-MUT ( > 0.05). The miR-339-5p group had lower protein levels of PTP4A1 and HMGB1 than the NC and miR-con groups ( < 0.05). The development of vascular-like structures was substantially more significant in the miR-con +PTP4A1 group than in the miR-con and miR-339-5p +PTP4A1 groups ( < 0.05). In terms of migration and invasion index, there was a substantial difference between the miR-339-5p +PTP4A1 and the miR-con +PTP4A1 groups ( < 0.05). The miR-con +PTP4A1 group had a greater migration rate and invasive index than the miR-con and miR-339-5p +PTP4A1 groups ( < 0.05).
MiR-339-5P inhibits angiogenic mimicry, migration, and invasion of brain glioma U251 cells by inhibiting the PTP4A1/HMGB1 signal pathway.
通过 PTP4A1/HMGB1 通路寻找 miR-339-5p 在神经胶质瘤中的抑制功能。
2020 年 5 月至 2021 年 8 月,选取 20 例胶质母细胞瘤及癌旁组织进行 qRT-PCR 分析。将 miR-NC、miR-con、miR-339-5PMIMIC 和 miR-con+ 转染至人神经胶质瘤 U251 细胞。通过模拟血管生成来发现细胞血管样结构构建的能力,并通过细胞划痕检测细胞的运动能力。双荧光素酶报告基因法确定 miR-339-5p 靶向 PTP4A1,Western blot 检测 PTP4A1 和 HMGB1 的蛋白表达水平。
癌组织中 miR-339-5P 的表达明显低于非癌组织(<0.05)。癌组织中 PTP4A1 的表达高于健康对照组(<0.05)。miR-339-5p 组形成的血管样结构明显少于 NC 和 miR-con 组(<0.05)。miR-339-5p 组降低了 U251 细胞的侵袭指数和迁移率(<0.05)。PTP4A1 抑制了 pTP4A1-WT 报告基因的荧光素酶活性(<0.05),但不抑制 PTP4A1-MUT(>0.05)。miR-339-5p 组的 PTP4A1 和 HMGB1 蛋白水平低于 NC 和 miR-con 组(<0.05)。miR-con+PTP4A1 组的血管样结构发育明显大于 miR-con 和 miR-339-5p+PTP4A1 组(<0.05)。在迁移和侵袭指数方面,miR-339-5p+PTP4A1 组与 miR-con+PTP4A1 组之间存在显著差异(<0.05)。miR-con+PTP4A1 组的迁移率和侵袭指数均高于 miR-con 和 miR-339-5p+PTP4A1 组(<0.05)。
miR-339-5P 通过抑制 PTP4A1/HMGB1 信号通路抑制脑胶质瘤 U251 细胞的血管生成模拟、迁移和侵袭。